Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multinational, Multicenter, Single Blood Sampling Exploratory Pharmacogenetic Study of the REGARD (the REbif vs Glatiramer Acetate in Relapsing MS Disease) Trial [SUBSTUDY OF 700004881]

Next Previous
Trial Profile

A Multinational, Multicenter, Single Blood Sampling Exploratory Pharmacogenetic Study of the REGARD (the REbif vs Glatiramer Acetate in Relapsing MS Disease) Trial [SUBSTUDY OF 700004881]

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Interferon beta-1a (Primary) ; Glatiramer acetate
  • Indications Multiple sclerosis
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms REGARD-PGx
  • Sponsors EMD Serono

Most Recent Events

  • 29 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 23 Dec 2010 Planned end date changed from 1 Oct 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
  • 23 Dec 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top